| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Advancing Alzheimer's disease drug review as a national priority
|
Perry, Daniel P.
|
|
2009
|
5 |
2 |
p. 180-181
2 p.
|
article
|
| 2 |
Alzheimer's Disease Anti-Inflammatory Prevention Trial: Design, methods, and baseline results
|
|
|
2009
|
5 |
2 |
p. 93-104
12 p.
|
article
|
| 3 |
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008
|
Khachaturian, Zaven S.
|
|
2009
|
5 |
2 |
p. 85-92
8 p.
|
article
|
| 4 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” A federally funded corporation for the prevention and treatment of cognitive impairment and brain aging
|
Schneider, Lon S.
|
|
2009
|
5 |
2 |
p. 172-179
8 p.
|
article
|
| 5 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Alzheimer's disease translational research programs at the National Institute on Aging
|
Petanceska, Suzana
|
|
2009
|
5 |
2 |
p. 130-132
3 p.
|
article
|
| 6 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” A national registry on aging
|
Petersen, Ronald C.
|
|
2009
|
5 |
2 |
p. 105-107
3 p.
|
article
|
| 7 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” A national registry to identify a cohort for Alzheimer's disease prevention studies
|
Sabbagh, Marwan N.
|
|
2009
|
5 |
2 |
p. 128-129
2 p.
|
article
|
| 8 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” A proposal to increase participation in Alzheimer's disease clinical trials
|
Ryan, J. Michael
|
|
2009
|
5 |
2 |
p. 140-142
3 p.
|
article
|
| 9 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” “Big Asks”: What can be changed to increase and speed progress on Alzheimer's disease research and treatment?
|
Kukull, Walter A.
|
|
2009
|
5 |
2 |
p. 137-139
3 p.
|
article
|
| 10 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Centers of excellence in Alzheimer's disease: It is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease
|
Doody, Rachelle S.
|
|
2009
|
5 |
2 |
p. 133-136
4 p.
|
article
|
| 11 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Comments from abroad
|
Korczyn, Amos D.
|
|
2009
|
5 |
2 |
p. 157-158
2 p.
|
article
|
| 12 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Establishing a national biomarker database: Utility and incentives
|
Cummings, Jeffrey L.
|
|
2009
|
5 |
2 |
p. 108-113
6 p.
|
article
|
| 13 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Facilitating Alzheimer's disease drug development in the United States
|
Aisen, Paul S.
|
|
2009
|
5 |
2 |
p. 125-127
3 p.
|
article
|
| 14 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Innovations in care that advance Alzheimer's disease drug development
|
Foster, Norman L.
|
|
2009
|
5 |
2 |
p. 159-162
4 p.
|
article
|
| 15 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: Opportunities and challenges
|
Ringman, John M.
|
|
2009
|
5 |
2 |
p. 166-171
6 p.
|
article
|
| 16 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Primary prevention of dementia in Alzheimer's disease: A perspective from prevention research in cardiovascular disease and stroke
|
Fillit, Howard
|
|
2009
|
5 |
2 |
p. 149-153
5 p.
|
article
|
| 17 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients
|
Simpkins, James W.
|
|
2009
|
5 |
2 |
p. 143-146
4 p.
|
article
|
| 18 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Recruitment of participants for Alzheimer's disease clinical trials: The role of trust in caregivers, clinical researchers, regulatory authorities, and industry sponsors
|
Snyder, Peter J.
|
|
2009
|
5 |
2 |
p. 122-124
3 p.
|
article
|
| 19 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal Symposium 2008.” Subjective cognitive impairment as an antecedent of Alzheimer's dementia: Policy import
|
Reisberg, Barry
|
|
2009
|
5 |
2 |
p. 154-156
3 p.
|
article
|
| 20 |
Commentary on “A roadmap for the prevention of dementia II: Leon Thal symposium 2008.” The megacommunity approach to Alzheimer's disease
|
Van Lee, Reggie
|
|
2009
|
5 |
2 |
p. 163-165
3 p.
|
article
|
| 21 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” The Multidomain Alzheimer Preventive Trial (MAPT): A new approach to the prevention of Alzheimer's disease
|
Gillette-Guyonnet, Sophie
|
|
2009
|
5 |
2 |
p. 114-121
8 p.
|
article
|
| 22 |
Commentary on “A roadmap for the prevention of dementia II. Leon Thal Symposium 2008.” Who may benefit from disease-modifying studies in Alzheimer's disease?
|
Gauthier, Serge
|
|
2009
|
5 |
2 |
p. 147-148
2 p.
|
article
|
| 23 |
Contents
|
|
|
2009
|
5 |
2 |
p. A3-A5
nvt p.
|
article
|
| 24 |
Early risk assessment for Alzheimer's disease
|
Carrillo, Maria C.
|
|
2009
|
5 |
2 |
p. 182-196
15 p.
|
article
|
| 25 |
Editorial Board
|
|
|
2009
|
5 |
2 |
p. A6-
1 p.
|
article
|
| 26 |
Join Advocates for Increased Alzheimer Research Funding at Public Policy Forum: Your Voice Has Never Been More Important
|
|
|
2009
|
5 |
2 |
p. 197-198
2 p.
|
article
|
| 27 |
Medical and Scientific Advisory Council
|
|
|
2009
|
5 |
2 |
p. A7-
1 p.
|
article
|
| 28 |
Prevent Alzheimer's disease by 2020: A national strategic goal
|
Khachaturian, Zaven S.
|
|
2009
|
5 |
2 |
p. 81-84
4 p.
|
article
|
| 29 |
Subscriber information page
|
|
|
2009
|
5 |
2 |
p. A2-
1 p.
|
article
|
Journal description